Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Misoprostol for Blood Loss in Cesarean Delivery
NCT03140033Phase 2Unknown
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Misoprostol Arm with Placebo Arm (2 arms). Primary endpoint: Blood loss during cesarean sections. Status: unknown.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03140033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140033.